Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study

The study has determined that the NSAD and other assessments are valid and reliable measures for quantifying the level of disease impairment in individuals with LGMDR1.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2025-04-16
DOI
https://doi.org/10.1002/acn3.70049
Citations
1
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study

Nikia Stinson, Shelley Mockler, Amanda Clause, Nicholas E. Johnson et al.
1 citations
Annals of Clinical and Translational Neurology
Muscle Physiology and Disorders
0.81
article

Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study

Nikia Stinson, Shelley Mockler, Amanda Clause, Nicholas E. Johnson, Robert Will, Molly M. Stark, Talia R. Strahler, M. Iammarino, Conrad C. Weihl, Lindsay N. Alfano, M. James, Aileen Jones, Natalie F. Reash, Stacy Dixon, Renee Augsburger, Katherine D. Mathews, Peter B. Kang, Jeffrey Statland, Katie M. Laubscher, Lindsay Pietruszewski, Sandhya Sasidharan, Doris G. Leung, Melissa Currence, Matthew Wicklund, Tahseen Mozaffar, Stephanie Hunn, Amanda Butler, Linda Lowes, R. Horton
article en
1 citations

Abstract

The study has determined that the NSAD and other assessments are valid and reliable measures for quantifying the level of disease impairment in individuals with LGMDR1.

Annals of Clinical and Translational NeurologyVol. 12(6)
Kennedy Krieger Institute (US), Nationwide Children's Hospital (US), Virginia Commonwealth University (US), University of California, Irvine (US), Washington University in St. Louis (US), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), University of Kansas Medical Center (US), University of Minnesota Medical Center (US), University of Iowa Health Care (US), The Ohio State University (US), Newcastle University (GB), University of Colorado Denver (US)
Jain Foundation, Pfizer, Sanofi, Muscular Dystrophy Association, Biogen, Alexion Pharmaceuticals, CSL Behring, Cumberland Pharmaceuticals, Virginia Commonwealth University, Seattle Children's Research Institute, Vertex Pharmaceuticals, Children’s Hospital of Wisconsin Research Institute, PTC Therapeutics, REGENXBIO, Sarepta Therapeutics, Amicus Therapeutics, Harmony Biosciences, Argenx, Newcastle University, Italfarmaco, National Institutes of Health, Sanofi Genzyme
Openalex Percentile: Top 29%
Muscle Physiology and Disorders
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.